journal article·2024-01Open access

Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and Activatability

Lingxiao Li, Tian Liu, Shiyi Zuo, Yaqiao Li, Erwei Zhao, Qi Lu, Danping Wang, Yixin Sun, Zhonggui He, Bingjun Sun, Jin Sun

Advanced Materials· Volume 36· Issue 4

Abstract

Abstract Homodimeric prodrug nanoassemblies (HDPNs) hold promise for improving the delivery efficiency of chemo‐drugs. However, the key challenge lies in designing rational chemical linkers that can simultaneously ensure the chemical stability, self‐assembly stability, and site‐specific activation of prodrugs. The “in series” increase in sulfur atoms, such as trisulfide bond, can improve the assembly stability of HDPNs to a certain extent, but limits the chemical stability of prodrugs. Herein, trithiocarbonate bond (─SC(S)S─), with a stable “satellite‐type” distribution of sulfur atoms, is developed via the insertion of a central carbon atom in trisulfide bonds. ─SC(S)S─ bond effectively addresses the existing predicament of HDPNs by improving the chemical and self‐assembly stability of homodimeric prodrugs while maintaining the on‐demand bioactivation. Furthermore, ─SC(S)S─ bond inhibits antioxidant defense system, leading to up‐regulation of the cellular ROS and apoptosis of tumor cells. These improvements of ─SC(S)S─ bond endow the HDPNs with in vivo longevity and tumor specificity, ultimately enhancing the therapeutic outcomes. ─SC(S)S─ bond is, therefore, promising for overcoming the bottleneck of HDPNs for efficient oncological therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Click Chemistry and Applications · Carbon dioxide utilization in catalysis · Sulfur-Based Synthesis Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (41)

Show source-provided references
1. 10.1093/annonc/mdw27110.1093/annonc/mdw271 ↗
2. 10.1038/nrclinonc.2016.6410.1038/nrclinonc.2016.64 ↗
3. 10.1038/nrc152910.1038/nrc1529 ↗
4. 10.1002/btm2.1000310.1002/btm2.10003 ↗
5. 10.1002/btm2.1014310.1002/btm2.10143 ↗
6. 10.1039/C6CS00592F10.1039/C6CS00592F ↗
7. 10.1038/s41565-021-01017-910.1038/s41565-021-01017-9 ↗
8. 10.1038/s41573-020-0090-810.1038/s41573-020-0090-8 ↗
9. 10.1002/wnan.167010.1002/wnan.1670 ↗
10. 10.1038/s41563-021-01047-710.1038/s41563-021-01047-7 ↗
11. 10.1038/s41551-021-00698-w10.1038/s41551-021-00698-w ↗
12. 10.1039/C7CS00521K10.1039/C7CS00521K ↗
13. 10.1039/D2SC01003H10.1039/D2SC01003H ↗
14. 10.1002/smll.20210146010.1002/smll.202101460 ↗
15. 10.1002/advs.20210145410.1002/advs.202101454 ↗
16. 10.1016/j.jconrel.2023.02.01310.1016/j.jconrel.2023.02.013 ↗
17. 10.1002/adma.20180588810.1002/adma.201805888 ↗
18. 10.1002/adma.20180300110.1002/adma.201803001 ↗
19. Li G. · Acta Mater. Med. · 2023 · 2 · 54
20. 10.1021/ja513034e10.1021/ja513034e ↗
21. 10.1016/j.ajps.2021.02.00210.1016/j.ajps.2021.02.002 ↗
22. 10.1016/j.ajps.2022.02.00210.1016/j.ajps.2022.02.002 ↗
23. 10.1016/j.jconrel.2018.04.01910.1016/j.jconrel.2018.04.019 ↗
24. Wang Q. · Chem. Anal. Biol. Fate: Polynucl. Aromat. Hydrocarbons, Int. Symp., 5th · 2022 · 34 · 2085
25. 10.1038/s41467-022-35033-710.1038/s41467-022-35033-7 ↗
26. 10.1021/acs.nanolett.8b0073710.1021/acs.nanolett.8b00737 ↗
27. 10.1038/s41467-019-11193-x10.1038/s41467-019-11193-x ↗
28. 10.1016/j.nantod.2022.10148010.1016/j.nantod.2022.101480 ↗
29. 10.1002/anie.20220116810.1002/anie.202201168 ↗
30. 10.1039/C4CS00219A10.1039/C4CS00219A ↗
31. 10.1039/D0CS01061H10.1039/D0CS01061H ↗
32. 10.1016/j.apsb.2021.05.00310.1016/j.apsb.2021.05.003 ↗
33. 10.7150/thno.8785410.7150/thno.87854 ↗
34. 10.1126/sciadv.abc172510.1126/sciadv.abc1725 ↗
35. 10.1002/anie.20220053510.1002/anie.202200535 ↗
36. 10.1002/anie.20191343010.1002/anie.201913430 ↗
37. 10.1039/C8PY01031E10.1039/C8PY01031E ↗
38. 10.1002/adma.20221001710.1002/adma.202210017 ↗
39. 10.1021/jacs.2c0880210.1021/jacs.2c08802 ↗
40. 10.1021/jm501650710.1021/jm5016507 ↗
41. 10.1021/acs.molpharmaceut.8b0033810.1021/acs.molpharmaceut.8b00338 ↗